11.09.2017 To the attention of interested persons EMA press release: PRAC recommends modified-release paracetamol be removed from market download document […]

07.09.2017 To the attention of interested persons PRAC confirms its previous conclusion on risk of inhibitor development with factor VIII […]

16.08.2017 To the attention of interested persons EMA seeks views of public during its safety review of valproate Registration opens […]

04.08.2017 To the attention of interested persons CMDh confirms that methylprednisolone injections containing lactose must not be given to patients […]

31.07.2017 To the attention of interested persons EMA’s final opinion confirms restrictions on use of linear gadolinium agents in body […]

11.07.2017 To the attention of interested persons EMA restricts use of multiple sclerosis medicine Zinbryta download document …

11.07.2017 To the attention of interested persons PRAC recommends that injectable methylprednisolone products containing lactose must not be given to […]

10.07.2017 To the attention of interested persons PRAC confirms restrictions on the use of linear gadolinium agents download document …

29.06.2017 To the attention of interested persons EMA recommends that Symbioflor 2 can continue to be used for irritable bowel […]

14.06.2017 To the attention of interested persons PRAC concludes there is no evidence of a change in known risk of […]